Department of Pharmacy, Affiliated Hospital of Qingdao University, Qingdao, China.
Key Laboratory of Pharmaceutical Research for Metabolic Diseases, Department of Pharmacy, Qingdao University of Science & Technology, Qingdao, China.
J Food Biochem. 2022 Jul;46(7):e14134. doi: 10.1111/jfbc.14134. Epub 2022 Mar 25.
Malus toringoides (Rehd.) Hughes, as a traditional medicinal and edible plant used in Tibet, China, is used to treat hypertension, hyperlipidemia, and liver diseases. In recent decades, excessive fructose intake with diet has greatly increased the occurrence of a series of metabolic diseases including obesity, insulin resistance, hypertension, and hyperlipidemia. The present study was designed to investigate the effects of an ethanol extract of M. toringoides (EMT) on glucose and lipid metabolism and liver injury in high fructose-induced mice. The C57BL/6J male mice were orally administrated with 30% fructose solution for 8 weeks, and EMT was given orally for another 8 weeks. The level of liver lipids related parameters, hepatic oxidative stress, and inflammatory mediators was detected by the kits. The improving effects of EMT on liver injury and lipid accumulation of mice were observed by hematoxylin and eosin staining and Oil Red O staining. In vitro, the hypolipidemic effect of EMT on palmitic acid-induced HepG2 cells was detected by the kits and Oil Red O staining. Our results showed that EMT has the hypolipidemic effect in vivo and in vitro, and can improve liver injury caused by fructose intake though ameliorating oxidative stress and inflammatory responses. Thus, we suggested that EMT may be a candidate therapeutic agent to improve a series of metabolic diseases including obesity, insulin resistance, and hyperlipidemia. PRACTICAL APPLICATIONS: Our study was aimed to find a novel candidate drug for liver diseases using natural products. We assessed the protective effects of Malus toringoides (Rehd.) Hughes in the pathogenesis of glucose and lipid metabolism. In vivo, the plant significantly improved the disorder of blood lipid and blood glucose, and liver injury in mice induced by fructose, and in vitro, this plant significantly improved the lipid accumulation of HepG2 cells induced by palmitic acid. To sum up, our studies suggested that the plant may be beneficial in the prevention and management of diet-induced abnormal glucose and lipid metabolism and liver diseases. Therefore, it will be a candidate therapeutic agent to improve liver diseases.
苹果属植物(红富士),作为中国西藏传统的药用和食用植物,用于治疗高血压、高血脂和肝病。近几十年来,饮食中过量摄入果糖极大地增加了一系列代谢性疾病的发生,包括肥胖、胰岛素抵抗、高血压和高血脂。本研究旨在探讨红富士乙醇提取物(EMT)对高果糖诱导的小鼠葡萄糖和脂质代谢及肝损伤的影响。雄性 C57BL/6J 小鼠口服 30%果糖溶液 8 周,另给予 EMT 口服 8 周。试剂盒检测肝脂相关参数、肝氧化应激和炎症介质水平。通过苏木精和伊红染色和油红 O 染色观察 EMT 对小鼠肝损伤和脂质积累的改善作用。体外,试剂盒和油红 O 染色检测 EMT 对棕榈酸诱导的 HepG2 细胞的降脂作用。我们的结果表明,EMT 在体内和体外均具有降脂作用,并通过改善氧化应激和炎症反应改善果糖摄入引起的肝损伤。因此,我们认为 EMT 可能是改善肥胖、胰岛素抵抗和高血脂等一系列代谢性疾病的候选治疗药物。实际应用:本研究旨在利用天然产物寻找治疗肝脏疾病的新型候选药物。我们评估了苹果属植物在葡萄糖和脂质代谢发病机制中的保护作用。在体内,该植物显著改善了果糖诱导的小鼠血脂和血糖紊乱及肝损伤,在体外,该植物显著改善了棕榈酸诱导的 HepG2 细胞的脂质积累。综上所述,我们的研究表明,该植物可能有益于预防和管理饮食引起的异常葡萄糖和脂质代谢及肝脏疾病。因此,它将成为改善肝脏疾病的候选治疗药物。